Arcus Biosciences Inc (RCUS)
15.70
+0.20
(+1.29%)
USD |
NYSE |
May 03, 16:00
15.66
-0.04
(-0.25%)
After-Hours: 20:00
Arcus Biosciences Revenue (TTM): 117.00M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 117.00M |
| September 30, 2023 | 120.00M |
| June 30, 2023 | 121.00M |
| March 31, 2023 | 119.00M |
| December 31, 2022 | 112.00M |
| September 30, 2022 | 432.62M |
| June 30, 2022 | 409.08M |
| March 31, 2022 | 391.54M |
| December 31, 2021 | 383.00M |
| September 30, 2021 | 38.35M |
| June 30, 2021 | 93.42M |
| March 31, 2021 | 85.71M |
| Date | Value |
|---|---|
| December 31, 2020 | 78.00M |
| September 30, 2020 | 77.78M |
| June 30, 2020 | 15.00M |
| March 31, 2020 | 15.00M |
| December 31, 2019 | 15.00M |
| September 30, 2019 | 6.812M |
| June 30, 2019 | 9.353M |
| March 31, 2019 | 8.853M |
| December 31, 2018 | 8.353M |
| September 30, 2018 | 8.041M |
| June 30, 2018 | 3.913M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
6.812M
Minimum
Sep 2019
432.62M
Maximum
Sep 2022
138.93M
Average
93.42M
Median
Jun 2021
Revenue (TTM) Benchmarks
| Gilead Sciences Inc | 27.45B |
| Catalyst Pharmaceuticals Inc | 398.20M |
| Integra Lifesciences Holdings Corp | 1.542B |
| Vertex Pharmaceuticals Inc | 9.869B |
| Adverum Biotechnologies Inc | -- |